GlassScriptPhysician profile
Shahnaz Bari
NPI 1679540215
$4,866.42
in general payments reported to CMS, 2019-2025
19 companies · $271 in 2025
The $271 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $140 · 2021: $1,281 · 2022: $293 · 2023: $1,128 · 2024: $1,325 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,520 · Travel and Lodging: $1,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,519.98 |
| Travel and Lodging | $1,203.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,463.69 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $1,215.84 | 2019-2024 | Proclaim, Prodigy, Eterna |
| Nevro Corp. | $876.84 | 2019-2024 | Senza |
| Medtronic, INC. | $527.67 | 2021-2024 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| International Rehabilitative Sciences, INC | $199.32 | 2025 | Rs-4i Plus With Intersperse |
| Biodelivery Sciences International, INC. | $148.33 | 2019-2021 | |
| Spr Therapeutics, INC | $95.73 | 2024 | Sprint Pns System |
| Ibsa Pharma INC. | $73.20 | 2021 | |
| Heron Therapeutics, INC. | $50.00 | 2025 | Aponvie |
| Bioventus LLC | $46.07 | 2022-2023 | Durolane |
| Medtronic USA, INC. | $34.32 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $23.15 | 2023 | Ztlido |
| Eagle Pharmaceuticals, INC. | $20.79 | 2022 | |
| Averitas Pharma INC. | $17.27 | 2023 | Qutenza |
| Idorsia Pharmaceuticals US INC | $16.41 | 2023 | Quviviq |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $15.98 | 2021 | |
| Protega Pharmaceutials INC | $15.90 | 2023 | Roxybond |
| Avanos Medical | $13.28 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $12.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shahnaz Bari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.